Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Questions India Faces As It Readies COVID-19 Vaccinations

Which Will Be Used?

Dec 17 2020

• By Vibha Ravi

Business woman with arrows and questions sign above isolated on white background — India's COVID-19 Vaccine Strategy Necessitates Careful Consideration • Source: Shutterstock

Related Content

Pfizer, Serum File EUAs For COVID-19 Vaccines In India

Dec 07 2020

Waters Muddied As Bharat Readies COVID-19 Vaccine For '21 Launch

Nov 27 2020

COVID-19: US FDA Weighing UK Anaphylactic Reaction Reports For Pfizer Vaccine Labeling

Dec 11 2020

Severe and Asymptomatic Data Could Give Moderna’s COVID-19 Vaccine Slight Edge Over Pfizer’s

Dec 15 2020

India Remdesivir Black Market: Supply Gap May Normalize Soon, But No End To Greed

Jul 20 2020

Related Companies

AstraZeneca PLC

University of Oxford

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Dr. Reddy's Laboratories Ltd.

Biological E Limited.

Gilead Sciences, Inc.

Novavax, Inc.

Moderna, Inc.

Pfizer Inc.

BioNTech SE

Additional Topics

India Asia Pacific Coronavirus COVID-19 Vaccines BioPharmaceutical

More from India

More from Focus On Asia

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window